What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update
Dale J. Langford, Ralf Baron, Robert R. Edwards, Jennifer S. Gewandter, Ian Gilron, Robert Griffin, Peter Kamerman, Nathaniel P. Katz, Michael P. McDermott, Andrew S.C. Rice, Dennis C. Turk, Jan Vollert, Robert H. Dworkin
Abstract
In Brief Updated IMMPACT recommendations suggest minimum baseline pain intensity remain ≥4 of 10 for phase 2 and 3 clinical trials of chronic pain treatments.
Topics & Concepts
MedicineClinical trialChronic painIntensity (physics)Physical therapyInternal medicinePhysicsQuantum mechanicsPain Mechanisms and TreatmentsPain Management and Placebo EffectPain Management and Opioid Use